Sarepta: brands it owns and its ownership tree
Sarepta (NASDAQ: SRPT) is a publicly listed company headquartered in Cambridge, United States that owns 4 consumer brands.[1]
Sarepta is a US company that develops treatments for Duchenne muscular dystrophy. Its 2025 Form 10-K reports sales of Elevidys and three exon-skipping medicines.
-
brands owned
-
1
categories
-
0
acquisitions recorded
-
0
subsidiaries recorded
Company facts
- Legal name
- Sarepta Therapeutics, Inc.
- Headquarters
- 🇺🇸 Cambridge, United States
- Type
- publicly listed company · all publicly listed company owners
- Tickers
- NASDAQ: SRPT
- Identifiers
- SEC CIK 0000873303
- Last verified
- · 1 sources
Brands Sarepta owns
4 brands in 1 category.
Drug makers (4)
- Amondys 45
Biotechnology · 🇺🇸 United States
- Elevidys
Biotechnology · 🇺🇸 United States
- Exondys 51
Biotechnology · 🇺🇸 United States
- Vyondys 53
Biotechnology · 🇺🇸 United States
Full list of 4 brands with sources · Interactive ownership tree
Ownership structure
No company is recorded as controlling Sarepta.
Financials and filings
Sarepta financial history
Headline figures from Sarepta's annual reports filed with the US Securities and Exchange Commission, in USD as reported, fiscal years ending 2020–2025. Revenue moved from $455.9m to $1.86bn, an average of 32.5% a year (calculated).
| Fiscal year ended | Revenue | Operating income | Operating margin | Net income | Total assets | Long-term debt | Filing |
|---|---|---|---|---|---|---|---|
| $1.86bn | $-699,781,000 | -37.5% | $-713,410,000 | $3.35bn | — | 10-K | |
| $1.79bn | $218.1m | 12.2% | $235.2m | $3.96bn | — | 10-K | |
| $1.14bn | $-267,824,000 | -23.4% | $-535,977,000 | $3.26bn | — | 10-K | |
| $843.8m | $-536,201,000 | -63.5% | $-703,488,000 | $3.13bn | — | 10-K | |
| $612.4m | $-459,710,000 | -75.1% | $-418,780,000 | $3.15bn | — | 10-K | |
| $455.9m | $-564,163,000 | -123.8% | $-554,128,000 | $2.98bn | — | 10-K |
Source: SEC XBRL company facts. A dash means the company did not report that line in a form we could read. Figures for a year can be restated in a later filing; the latest filing's number is shown.
Sarepta SEC filings
The documents behind the figures on this page, as listed in the SEC's EDGAR index. Each links to the filing itself.
Annual reports
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
Proxy statements
- Proxy statement, filed (DEF 14A)
- Proxy statement, filed (DEF 14A)
- Proxy statement, filed (DEF 14A)
Recent current and quarterly reports
| Filed | Form | What it declares |
|---|---|---|
| 8-K | Results of operations and financial condition | |
| 10-Q | Quarterly report | |
| 8-K | Entry into a material agreement | |
| 8-K | Results of operations and financial condition | |
| 10-Q | Quarterly report | |
| 8-K | Departure or appointment of directors or officers; Regulation FD disclosure | |
| 8-K | Departure or appointment of directors or officers; Results of a shareholder vote | |
| 8-K | Results of operations and financial condition | |
| 10-Q | Quarterly report | |
| 8-K | Departure or appointment of directors or officers | |
| 8-K | Results of operations and financial condition | |
| 8-K | Results of operations and financial condition | |
| 8-K | Entry into a material agreement; Creation of a direct financial obligation | |
| 8-K | Unregistered sales of equity securities; Other events |
Sarepta in the global legal-entity registry
The Global Legal Entity Identifier Foundation (GLEIF) keeps an open register of legal entities. Each entity reports its own parents. We show it as a cross-check on the ownership recorded on this page, which is built from filings.
- Legal entity identifier (LEI)
- 549300IKDPIED8J8IG21
- Registered name
- SAREPTA THERAPEUTICS, INC. (US)
- Registration status
- Issued · record updated 5 August 2026
- Parent
- None named: it reports that it has no parent that consolidates its accounts.
- Retrieved
- · GLEIF record (JSON)
Frequently asked questions
What brands does Sarepta own?
Sarepta owns 4 consumer brands tracked here, including Amondys 45, Exondys 51, Vyondys 53 and Elevidys.
Is Sarepta an American company?
Yes. Sarepta is headquartered in Cambridge, United States.
Who owns Sarepta?
Sarepta is a publicly listed company owned by its shareholders; it trades as SRPT on the NASDAQ.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Sarepta Therapeutics, Inc. Annual Report on Form 10-K filed 2026-03-02 — SEC EDGAR, SEC Form 10-K, published 2 March 2026; retrieved 8 November 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.